ロード中...
Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma
BACKGROUND: Alpha-l-fucosidase (AFU) not only detects hepatocellular carcinoma (HCC) early but also is used as a clinical prognostic indicator of several malignant tumors. However, no study has investigated the prognostic significance of AFU in a cohort of patients with esophageal squamous cell carc...
保存先:
| 出版年: | J Thorac Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790429/ https://ncbi.nlm.nih.gov/pubmed/31656672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.08.92 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|